Mickle Travis C
SEC CIK 1638365 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZVRA | ZEVRA THERAPEUTICS, INC. | Pres, CEO, Dir | 38.5K | $120.1K | — | 6 | 2021-08-24 | 2022-05-25 |
Most active insiders at ZVRA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | McFarlane Neil F. | Pres, CEO, Dir | — | $1.19M |
| 2 | Thompson Rahsaan | Chief Legal, Compliance, Sec | — | $969.4K |
| 3 | Watton Corey Michael | Dir | — | $138.4K |
| 4 | Schafer Joshua | CCO | — | $126.3K |
| 5 | Sangiovanni Timothy J. | SVP, Fin, Corp Ctrl | — | $43.0K |
| 6 | Quartel Adrian W | Chief Medical Off | — | $40.0K |
| 7 | Bode John B | Dir | — | — |
| 8 | Clifton R. LaDuane | Former CFO, Treas | — | — |
Mickle Travis C made no open-market trades at ZVRA in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-25 | 2022-05-25 | ZVRA | ZEVRA THERAPEUTICS, INC. | Mickle Travis C | Pres, CEO, Dir | P - Purchase | $4.37 | +3,000 | 38.5K | +8% | +$13.1K |
| I | 2022-05-25 | 2022-05-25 | ZVRA | ZEVRA THERAPEUTICS, INC. | Mickle Travis C | Pres, CEO, Dir | P - Purchase | $4.39 | +10.0K | 11.0K | +967% | +$43.9K |
| 2021-11-23 | 2021-11-18 | ZVRA | ZEVRA THERAPEUTICS, INC. | Mickle Travis C | Pres, CEO, Dir | P - Purchase | $8.23 | +2,250 | 36.5K | +7% | +$18.5K | |
| 2021-08-30 | 2021-08-30 | ZVRA | ZEVRA THERAPEUTICS, INC. | Mickle Travis C | Pres, CEO, Dir | P - Purchase | $8.92 | +5,000 | 34.3K | +17% | +$44.6K | |
| DM | 2021-08-24 | 2021-08-24 | ZVRA | ZEVRA THERAPEUTICS, INC. | Mickle Travis C | Pres, CEO, Dir | J - Other | $0.00 | -96.5K | 0 | -100% | $0 |
| DMI | 2021-08-24 | 2021-08-24 | ZVRA | ZEVRA THERAPEUTICS, INC. | Mickle Travis C | Pres, CEO, Dir | J - Other | $0.00 | +87.1K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations